ANUHPHR
Start SIP
Invest Now
Start SIP in ANUHPHR
Performance
- Low
- ₹72
- High
- ₹74
- 52 Week Low
- ₹70
- 52 Week High
- ₹115
- Open Price₹74
- Previous Close₹74
- Volume20,436
- 50 DMA₹78.42
- 100 DMA₹81.85
- 200 DMA₹86.47
Investment Returns
- Over 1 Month -6.49%
- Over 3 Month -12.47%
- Over 6 Month -26.73%
- Over 1 Year -29.42%
Smart Investing Starts Here Start SIP with Anuh Pharma for Steady Growth!
Anuh Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 18.9
- PEG Ratio
- -0.5
- Market Cap Cr
- 733
- P/B Ratio
- 2.2
- Average True Range
- 2.52
- EPS
- 3.86
- Dividend Yield
- 2.1
- MACD Signal
- -1.34
- RSI
- 34.69
- MFI
- 15.04
Anuh Pharma Financials
Anuh Pharma Technicals
EMA & SMA
Current Price
₹73.09
+
0.19
(0.26%)
- Bearish Moving Average 0
- Bullish Moving Average 0
- 20 Day
- ₹75.83
- 50 Day
- ₹78.42
- 100 Day
- ₹81.85
- 200 Day
- ₹86.47
Resistance and Support
72.57
- R3 74.74
- R2 73.96
- R1 73.35
- S1 71.96
- S2 71.18
- S3 70.57
Anuh Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-07 | Quarterly Results | |
| 2025-08-08 | Quarterly Results & Others | To consider other business matters. per share(30%)Final Dividend |
| 2025-05-23 | Audited Results, Dividend & Bonus issue | |
| 2025-02-07 | Quarterly Results & Others | To consider other business matters. per share(30%)Final Dividend |
| 2024-11-08 | Quarterly Results |
Anuh Pharma F&O
About Anuh Pharma
- NSE Symbol
- ANUHPHR
- BSE Symbol
- 506260
- Joint Managing Director
- Mr. Ritesh B Shah
- ISIN
- INE489G01022
Similar Stocks to Anuh Pharma
Anuh Pharma FAQs
Anuh Pharma share price is ₹73 As on 24 January, 2026 | 20:10
The Market Cap of Anuh Pharma is ₹732.5 Cr As on 24 January, 2026 | 20:10
The P/E ratio of Anuh Pharma is 18.9 As on 24 January, 2026 | 20:10
The PB ratio of Anuh Pharma is 2.2 As on 24 January, 2026 | 20:10
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.